NeuroPace (NPCE) Cash from Financing Activities (2020 - 2026)
NeuroPace's quarterly Cash from Financing Activities came in at -$166000.0 in Q1 2026, down 100.79% year-on-year from $21.1 million in Q1 2025, and down 126.14% quarter-over-quarter from $635000.0 in Q4 2025.
NeuroPace has reported Cash from Financing Activities for 7 years, with the latest figure at -$166000.0 in Q1 2026.
- For the quarter ending Q1 2026, Cash from Financing Activities fell 100.79% year-over-year to -$166000.0; the trailing twelve-month figure through Mar 2026 stood at -$1.7 million (down 106.6% YoY), and the FY2025 full-year result was $19.6 million, up 352.97% from the prior year.
- Cash from Financing Activities for Q1 2026 stood at -$166000.0, down from $635000.0 in the prior quarter.
- The five-year high for Cash from Financing Activities was $21.1 million in Q1 2025, with the low at -$1.9 million in Q2 2025.
- Average Cash from Financing Activities over 5 years is $1.9 million, with a median of $72000.0 recorded in 2024.
- Year-over-year, Cash from Financing Activities tumbled 25600.0% in 2023 and soared 29216.67% in 2025.
- Tracing NPCE's Cash from Financing Activities over 5 years: stood at -$138000.0 in 2022, then soared by 6052.17% to $8.2 million in 2023, then tumbled by 89.68% to $848000.0 in 2024, then dropped by 25.12% to $635000.0 in 2025, then plunged by 126.14% to -$166000.0 in 2026.
- The last three Cash from Financing Activities figures came in at -$166000.0 (Q1 2026), $635000.0 (Q4 2025), and -$235000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 17.31 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | -1.51 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | -2.09 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | -260.00 Mn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | -451.20 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -26.93 Mn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | -25.00 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 21.00 Mn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | -97.90 Mn |
| 10 | NeuroPace | 558.86 Mn | 504.88 Mn | 18.05 Mn | -166,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -166,000.00 |
| Mar 31, 2026 | -166,000.00 |
| Dec 31, 2025 | 635,000.00 |
| Dec 31, 2025 | 635,000.00 |
| Sep 30, 2025 | -235,000.00 |
| Sep 30, 2025 | -235,000.00 |
| Jun 30, 2025 | -1.91 Mn |
| Jun 30, 2025 | -1.91 Mn |
| Mar 31, 2025 | 21.11 Mn |
| Mar 31, 2025 | 21.11 Mn |
| Dec 31, 2024 | 848,000.00 |
| Dec 31, 2024 | 848,000.00 |
| Sep 30, 2024 | 2.90 Mn |
| Sep 30, 2024 | 2.90 Mn |
| Jun 30, 2024 | 509,000.00 |
| Jun 30, 2024 | 509,000.00 |
| Mar 31, 2024 | 72,000.00 |
| Mar 31, 2024 | 72,000.00 |
| Dec 31, 2023 | 8.21 Mn |
| Dec 31, 2023 | 8.21 Mn |
| Sep 30, 2023 | -27,000.00 |
| Sep 30, 2023 | -27,000.00 |
| Jun 30, 2023 | 195,000.00 |
| Jun 30, 2023 | 195,000.00 |
| Mar 31, 2023 | -255,000.00 |
| Mar 31, 2023 | -255,000.00 |
| Dec 31, 2022 | -138,000.00 |
| Dec 31, 2022 | -138,000.00 |
| Sep 30, 2022 | -8,000.00 |
| Sep 30, 2022 | -8,000.00 |
| Jun 30, 2022 | 635,000.00 |
| Jun 30, 2022 | 635,000.00 |
| Mar 31, 2022 | 1,000.00 |
| Mar 31, 2022 | 1,000.00 |
| Dec 31, 2021 | 911,000.00 |
| Dec 31, 2021 | 911,000.00 |
| Jun 30, 2021 | 103.19 Mn |
| Jun 30, 2021 | 103.19 Mn |
| Mar 31, 2021 | -1.58 Mn |
| Mar 31, 2021 | -1.58 Mn |
| Dec 31, 2020 | -279,000.00 |
| Dec 31, 2020 | -279,000.00 |
| Sep 30, 2020 | 38.82 Mn |
| Sep 30, 2020 | 38.82 Mn |
| Jun 30, 2020 | 3.95 Mn |
| Jun 30, 2020 | 3.95 Mn |
| Mar 31, 2020 | 12.52 Mn |
| Mar 31, 2020 | 12.52 Mn |